Related Experiment Video

Updated: Jun 7, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Dandy Walker malformation and hypertrophic cardiomyopathy. Unusual fatal association

Maher E Kurdi1, Mohammed A Chamsi-Pasha, Saleh S Baeesa

  • 1Department of Neurosciences, King Faisal Specialist Hospital & Research Center, Jeddah, Kingdom of Saudi Arabia.

Neurosciences (Riyadh, Saudi Arabia)
|November 5, 2010
PubMed

Insights

Dandy Walker malformation (DWM) can be linked to severe heart issues like hypertrophic cardiomyopathy, leading to heart failure. Early cardiac screening is crucial for infants diagnosed with DWM to detect these serious complications.

Area of Science:

  • Pediatric Neurology
  • Cardiology
  • Medical Genetics

Background:

  • Dandy-Walker malformation (DWM) is a rare congenital brain anomaly.
  • It involves cystic dilation of the fourth ventricle and cerebellar vermis hypoplasia.
  • Extracranial anomalies, including cardiac defects, can co-occur with DWM.

Purpose of the Study:

  • To report a rare case of DWM associated with hypertrophic cardiomyopathy and progressive heart failure.
  • To highlight the potential poor prognosis of this combined condition.
  • To emphasize the need for cardiac evaluation in DWM patients.

Main Methods:

  • Case report presentation.
  • Clinical diagnosis of DWM and hypertrophic cardiomyopathy.
  • Review of associated anomalies and patient outcome.

Main Results:

  • A patient with DWM developed progressive heart failure due to hypertrophic cardiomyopathy.
  • The patient was diagnosed at 2 months and died at 7 months of age.
  • This association indicates a potentially poor prognosis.

Conclusions:

  • Hypertrophic cardiomyopathy is a rare but serious cardiac malformation associated with DWM.
  • Infants with DWM require thorough cardiac evaluation for early detection of associated cardiac conditions.
  • Prompt recognition of cardiac issues in DWM can improve patient management and outcomes.

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...